Comparison of three screening test kits for G6PD enzyme deficiency: Implications for its use in the radical cure of vivax malaria in remote and resource-poor areas in the philippines

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Espino, Fe Esperanza ^a   Bibit, Jo Anne ^a   Sornillo, Johanna Beulah ^a   Tan, Alvin ^a   Von Seidlein, Lorenz ^b   Ley, Benedikt ^c  

^a RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^b MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE;

ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; COLORIMETRY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME ACTIVITY; FLUORESCENCE; FLUORESCENT SPOT TEST; FUNCTION TEST KIT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HETEROZYGOTE; HIGH SCHOOL STUDENT; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MALARIA RAPID TEST; PHILIPPINES; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POINT OF CARE TESTING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; SCREENING TEST KIT; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY; VENOUS BLOOD; ADOLESCENT; CHILD; COMPARATIVE STUDY; COMPLICATION; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE PLANNING; MALARIA, VIVAX; MALE; MASS SCREENING; POINT OF CARE SYSTEM; PROCEDURES; SUPPLY AND DISTRIBUTION; YOUNG ADULT;

ADOLESCENT; CHILD; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH RESOURCES; HUMANS; MALARIA, VIVAX; MALE; MASS SCREENING; PHILIPPINES; POINT-OF-CARE SYSTEMS; YOUNG ADULT;

EID: 84959130129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148172     Document Type: Article

References (34)

1. Galappaththy GN, Tharyan P, Kirubakaran R. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine. The Cochrane database of systematic reviews. 2013; 10: CD004389. doi: 10.1002/14651858.CD004389.pub3 PMID: 24163057
2. Manganelli G, Masullo U, Passarelli S, Filosa S. Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Cardiovascular & hematological disorders drug targets. 2013; 13 (1):73-82.
3. Hundsdoerfer P, Vetter B, Kulozik AE. Chronic haemolytic anaemia and glucose-6 phosphate dehydrogenase deficiency. Case report and review of the literature. Acta haematologica. 2002; 108(2):102-5. PMID: 12187030
4. Beutler E. Glucose-6-phosphate dehydrogenase deficiency. The New England journal of medicine. 1991; 324(3):169-74. PMID: 1984194
5. Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations. Blood cells, molecules & diseases. 2012; 48(3):154-65.
6. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood cells, molecules & diseases. 2009; 42(3):267-78.
7. Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, et al. Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malaria journal. 2013; 12:418. doi: 10.1186/1475-2875-12-418 PMID: 24228846
8. Leslie T, Briceno M, Mayan I, Mohammed N, Klinkenberg E, Sibley CH, et al. The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan. PLoS medicine. 2010; 7(5):e1000283. doi: 10.1371/journal.pmed. 1000283 PMID: 20520804
9. John GK, Douglas NM, von Seidlein L, Nosten F, Baird JK, White NJ, et al. Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malaria journal. 2012; 11:280. doi: 10.1186/1475-2875-11-280 PMID: 22900786
10. Fernando D, Rodrigo C, Rajapakse S. Primaquine in vivax malaria: an update and review on management issues. Malaria journal. 2011; 10:351. doi: 10.1186/1475-2875-10-351 PMID: 22152065
11. Walsh DS, Eamsila C, Sasiprapha T, Sangkharomya S, Khaewsathien P, Supakalin P, et al. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. The Journal of infectious diseases. 2004; 190(8):1456-63. PMID: 15378438
12. Ley B, Luter N, Espino FE, Devine A, Kalnoky M, Lubell Y, et al. The challenges of introducing routine G6PD testing into radical cure: a workshop report. Malaria journal. 2015; 14:377. doi: 10.1186/s12936-015-0896-8 PMID: 26416229
13. Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malaria journal. 2013; 12:391. doi: 10.1186/1475-2875-12-391 PMID: 24188096
14. von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malaria journal. 2013; 12:112. doi: 10.1186/1475-2875-12-112 PMID: 23537118
15. Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, Valentine WN. International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. British journal of haematology. 1979; 43(3):465-7. PMID: 497122
16. Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, et al. Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PloS one. 2011; 6 (12):e28357. doi: 10.1371/journal.pone.0028357 PMID: 22164279
17. Tantular IS, Kawamoto F. An improved, simple screening method for detection of glucose-6-phosphate dehydrogenase deficiency. Tropical medicine & international health: TM & IH. 2003; 8(6):569-74.
18. MPAC. Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria. Geneva, Switzerland: WHO, 2015.
19. Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, et al. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia. PloS one. 2014; 9(12): e116143. doi: 10.1371/journal.pone.0116143 PMID: 25541721
20. Bancone G, Chu CS, Chowwiwat N, Somsakchaicharoen R, Wilaisrisak P, Charunwatthana P, et al. Suitability of Capillary Blood for Quantitative Assessment of G6PD Activity and Performances of G6PD Point-of-Care Tests. The American journal of tropical medicine and hygiene. 2015.
21. Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bulletin of the World Health Organization. 1989; 67(6):601-11. PMID: 2633878
22. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS medicine. 2012; 9(11):e1001339. doi: 10.1371/journal.pmed.1001339 PMID: 23152723
23. Saha N. Distribution of glucose-6-phosphate dehydrogenase phenotypes in five East Asian population groups. Annals of the Academy of Medicine, Singapore. 1984; 13(3):494-7. PMID: 6517516
24. Padilla C, Nishiyama K, Shirakawa T, Matsuo M, Newborn Screening Study G. Screening for glucose-6-phosphate dehydrogenase deficiency using a modified formazan method: a pilot study on Filipino male newborns. Pediatrics international: official journal of the Japan Pediatric Society. 2003; 45(1):10-5.
25. Padilla CD. Newborn screening in the Philippines. The Southeast Asian journal of tropical medicine and public health. 2003; 34 Suppl 3:87-8. PMID: 15906705
26. Padilla CD, Therrell BL. Newborn screening in the Asia Pacific region. Journal of inherited metabolic disease. 2007; 30(4):490-506. PMID: 17643195
27. Padilla CD, Therrell BL Jr., Working Group of the Asia Pacific Society for Human Genetics on Consolidating Newborn Screening Efforts in the Asia Pacific R. Consolidating newborn screening efforts in the Asia Pacific region: Networking and shared education. Journal of community genetics. 2012; 3(1):35-45. doi: 10.1007/s12687-011-0076-7 PMID: 22271560
28. LaRue N, Kahn M, Murray M, Leader BT, Bansil P, McGray S, et al. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency. The American journal of tropical medicine and hygiene. 2014; 91(4):854-61. doi: 10.4269/ajtmh.14-0194 PMID: 25071003
29. Baird JK, Dewi M, Subekti D, Elyazar I, Satyagraha AW. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells. Translational research: the journal of laboratory and clinical medicine. 2014.
30. Meissner PE, Coulibaly B, Mandi G, Mansmann U, Witte S, Schiek W, et al. Diagnosis of red cell G6PD deficiency in rural Burkina Faso: comparison of a rapid fluorescent enzyme test on filter paper with polymerase chain reaction based genotyping. British journal of haematology. 2005; 131(3):395-9. PMID: 16225660
31. Kuwahata M, Wijesinghe R, Ho MF, Pelecanos A, Bobogare A, Landry L, et al. Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots. Malaria journal. 2010; 9:223. doi: 10.1186/ 1475-2875-9-223 PMID: 20684792
32. De Niz M, Eziefula AC, Othieno L, Mbabazi E, Nabukeera D, Ssemmondo E, et al. Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda. Malaria journal. 2013; 12:210. doi: 10.1186/1475-2875-12-210 PMID: 23782846
33. Adu-Gyasi D, Asante KP, Newton S, Dosoo D, Amoako S, Adjei G, et al. Evaluation of the Diagnostic Accuracy of CareStart G6PD Deficiency Rapid Diagnostic Test (RDT) in a Malaria Endemic Area in Ghana, Africa. PloS one. 2015; 10(4):e0125796. doi: 10.1371/journal.pone.0125796 PMID: 25885097
34. Ley B, Thriemer K, Ame SM, Mtove GM, von Seidlein L, Amos B, et al. Assessment and comparative analysis of a rapid diagnostic test (Tubex(R)) for the diagnosis of typhoid fever among hospitalized children in rural Tanzania. BMC Infect Dis. 2011; 11:147. doi: 10.1186/1471-2334-11-147 PMID: 21609455